To this point, despite the fact that PNPLA3 and TM6SF2 polymorphisms represent most commonly investigated lipid metabolism based host genetic variants in NAFLD, their potential influence in CHC mediated CLP is less defined. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.